We investigated whether tolvaptan, an orally active vasopressin V2-receptor antagonist that promotes aquaresis — excretion of electrolyte-free water — might be of benefit in hyponatremia
We investigated whether tolvaptan, an orally active vasopressin V2-receptor antagonistthat promotes aquaresis — excretion of electrolyte-free water — might be of benefitin hyponatremia